Literature DB >> 27641994

Olfactory ensheathing glia cell therapy and tubular conduit enhance nerve regeneration after mouse sciatic nerve transection.

Camila Oliveira Goulart1, Daniella de Freitas Pereira Ângelo Durço1, Lítia Alves de Carvalho2, Júlia Teixeira Oliveira1, Lucinéia Alves2, Leny A Cavalcante3, Ana Maria Blanco Martinez4.   

Abstract

The regenerative potential of the peripheral nervous system (PNS) is widely known, but functional recovery, particularly in humans, is seldom complete. Therefore, it is necessary to resort to strategies that induce or potentiate the PNS regeneration. Our main objective was to test the effectiveness of Olfactory Ensheathing Cells (OEC) transplantation into a biodegradable conduit as a therapeutic strategy to improve the repair outcome after nerve injury. Sciatic nerve transection was performed in C57BL/6 mice; proximal and distal stumps of the nerve were sutured into the collagen conduit. Two groups were analyzed: DMEM (acellular grafts) and OEC (1×105/2μL). Locomotor function was assessed weekly by Sciatic Function Index (SFI) and Global Mobility Test (GMT). After eight weeks the sciatic nerve was dissected for morphological analysis. Our results showed that the OEC group exhibited many clusters of regenerated nerve fibers, a higher number of myelinated fibers and myelin area compared to DMEM group. The G-ratio analysis of the OEC group showed significantly more fibers on the most suitable sciatic nerve G-ratio index. Motor recovery was accelerated in the OEC group. These data provide evidence that the OEC therapy can improve sciatic nerve functional and morphological recovery and can be potentially translated to the clinical setting.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell therapy; Ensheathing cells; Nerve conduit; Nerve regeneration; Olfactory; Peripheral nerve trauma

Mesh:

Year:  2016        PMID: 27641994     DOI: 10.1016/j.brainres.2016.09.021

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy.

Authors:  Litia A Carvalho; Jian Teng; Renata L Fleming; Elie I Tabet; Max Zinter; Ricardo A de Melo Reis; Bakhos A Tannous
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

2.  Lipid Rafts from Olfactory Ensheathing Cells: Molecular Composition and Possible Roles.

Authors:  Fernanda S O Campos; Felipe M Piña-Rodrigues; Alice Reis; Georgia C Atella; Claudia S Mermelstein; Silvana Allodi; Leny A Cavalcante
Journal:  Cell Mol Neurobiol       Date:  2020-05-15       Impact factor: 5.046

3.  Peripheral Nerve Regeneration Using a Nerve Conduit with Olfactory Ensheathing Cells in a Rat Model.

Authors:  Jong-Yoon Lee; Young-Ho Kim; Boo-Young Kim; Dae-Hyun Jang; Sung-Wook Choi; So-Hyun Joen; Hyungyun Kim; Sang-Uk Lee
Journal:  Tissue Eng Regen Med       Date:  2021-01-30       Impact factor: 4.169

Review 4.  Heterogeneity and Potency of Peripheral Glial Cells in Embryonic Development and Adults.

Authors:  Artem Sinegubov; Daria Andreeva; Nikita Burzak; Maria Vasyutina; Lada Murashova; Vyacheslav Dyachuk
Journal:  Front Mol Neurosci       Date:  2022-03-25       Impact factor: 5.639

Review 5.  The Effect of Schwann Cells/Schwann Cell-Like Cells on Cell Therapy for Peripheral Neuropathy.

Authors:  Qian Wang; Fang-Yu Chen; Zhuo-Min Ling; Wen-Feng Su; Ya-Yu Zhao; Gang Chen; Zhong-Ya Wei
Journal:  Front Cell Neurosci       Date:  2022-03-08       Impact factor: 5.505

Review 6.  The application of collagen in the repair of peripheral nerve defect.

Authors:  Xiaolan Li; Xiang Zhang; Ming Hao; Dongxu Wang; Ziping Jiang; Liqun Sun; Yongjian Gao; Ye Jin; Peng Lei; Yue Zhuo
Journal:  Front Bioeng Biotechnol       Date:  2022-09-23

7.  Extracellular Vesicles Derived From Olfactory Ensheathing Cells Promote Peripheral Nerve Regeneration in Rats.

Authors:  Bing Xia; Jianbo Gao; Shengyou Li; Liangliang Huang; Teng Ma; Laihe Zhao; Yujie Yang; Jinghui Huang; Zhuojing Luo
Journal:  Front Cell Neurosci       Date:  2019-12-06       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.